This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Sezgin, A. T. Articles by Ozdemir, R. Search for Related Content PubMed PubMed Citation Articles by Sezgin, A. T. Articles by Ozdemir, R. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CHOLESTEROL NITROGLYCERIN Social Bookmarking                   What's this?

Contribution of Plasma Lipid Disturbances to Vascular Endothelial Function in Patients With Slow Coronary Flow

Department of Cardiology, Baskent University, Practice and Research Hospital, Adana

Irfan Barutcu, MD

Department of Cardiology, Kocatepe University Faculty of Medicine, Afyon, irfanbarutcu{at}yahoo.com

Nurzen Sezgin, MD

Department of Biochemistry, Baskent University, Practice and Research Hospital, Adana

Hakan Gullu, MD

Faculty of Medicine, Department of Cardiology, Inonu University, Malatya, Turkey

Ali Metin Esen, MD

Department of Cardiology, Kocatepe University Faculty of Medicine, Afyon

Nusret Acikgoz, MD

Faculty of Medicine, Department of Cardiology, Inonu University, Malatya, Turkey

Ergun Topal, MD

Faculty of Medicine, Department of Cardiology, Inonu University, Malatya, Turkey

Ramazan Ozdemir, MD

Faculty of Medicine, Department of Cardiology, Inonu University, Malatya, Turkey

Previous studies have suggested that microcirculatory abnormalities cause slow coronary flow (SCF). However, the underlying mechanism of this phenomenon has not yet been well documented. Therefore, the aim of this study was to determine the role of plasma lipid disturbances in pathogenesis of slow coronary flow (SCF). Forty patients with SCF (group I) and 37 subjects with normal coronary arteries (group II) were included in the study. In each subject plasma lipid concentrations (total cholesterol [TC], low-density lipoprotein cholesterol [LDL-C], high-density lipoprotein cholesterol [HDL-C], and triglyceride [TG]) and brachial artery flow-mediated dilatation (FMD) and nitroglycerin (NTG)-induced dilatation were measured. Total cholesterol level was found to be similar in the 2 groups. In group I, HDL-C level was lower than in group II (34 ±3 vs 40 ±4 mg/dL, p=0.0001). In group I, TG level was higher than in group II (213 ±29 vs 198 ±24 mg/dL p=0.002). In group I, FMD was smaller than that of group II (3.48 ±3.1% vs 10.4 ±5.6%, p=0.0001). The percent NTG-induced dilatation was not different between the groups (15.5 ±5.3% vs 17.3 ±6.9%, p=0.27). On regression analysis; there was a significant relationship between percent of FMD and HDL-C (r =0.65, p=0.0001). When the 2 groups were analyzed separately, HDL-C was still related to percent of FMD in both groups (r =0.47 p=0.002 and r =0.45 p=0.005, respectively). Multivariate regression analysis showed that only plasma HDL-C was independently related to FMD (F=7.5 p=0.0001). In patients with SCF, reduced flow-mediated dilatation was detected and was found to be associated with plasma lipid disturbances, principally low HDL and high TG levels.

Angiology, Vol. 57, No. 6, 694-701 (2007)
DOI: 10.1177/0003319706295472


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?